Apontis Pharma AG (APPH.DE)
EUR 11.15
(0.45%)
EUR 11.15
(0.45%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -3.33 Million EUR | -109.43% |
| 2022 | 34.99 Million EUR | 3.56% |
| 2021 | 33.78 Million EUR | 35.01% |
| 2020 | 25.02 Million EUR | -13.62% |
| 2019 | 28.97 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 5.76 Million EUR | 216.09% |
| 2023 Q2 | 1.67 Million EUR | -78.39% |
| 2023 Q4 | -4.96 Million EUR | -395.96% |
| 2023 FY | -3.3 Million EUR | -109.43% |
| 2022 Q2 | 7.78 Million EUR | -9.09% |
| 2022 FY | 34.99 Million EUR | 3.56% |
| 2022 Q4 | 7.75 Million EUR | -0.32% |
| 2021 FY | 33.78 Million EUR | 35.01% |
| 2021 Q4 | 8.56 Million EUR | 125.33% |
| 2021 Q2 | 3.79 Million EUR | 0.0% |
| 2020 FY | 25.02 Million EUR | -13.62% |
| 2019 FY | 28.97 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| MPH Health Care AG | 180.33 Million EUR | 101.85% |
| Dermapharm Holding SE | 342.86 Million EUR | 100.973% |
| Evotec SE | 175.05 Million EUR | 101.906% |
| MERCK Kommanditgesellschaft auf Aktien | 11.66 Billion EUR | 100.029% |
| PharmaSGP Holding SE | 91.63 Million EUR | 103.641% |
| SynBiotic SE | 1.5 Million EUR | 321.466% |